Veracyte | VCYT - Debt


Veracyte reported $40.45M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Agenus USD 35.54M 2.34M Mar/2025
Agilent USD 3.35B 55M Sep/2025
Anika Therapeutics USD 0 0 Mar/2025
Arrowhead Research USD 366.28M 13.25M Sep/2025
Bruker USD 2.01B 426.8M Sep/2025
Heron Therapeutics USD 149.65M 157K Sep/2024
Illumina USD 2.58B 22M Sep/2025
Intrexon USD 0 13.82M Jun/2024
Karyopharm Therapeutics USD 299.23M 35.14M Dec/2025
Laboratory Of America USD 6.53B 16.1M Sep/2025
Ligand Pharmaceuticals USD 451M 445.26M Sep/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Rigel Pharmaceuticals USD 59.69M 90K Jun/2024
Roche Holding CHF 33.03B 1.41B Jun/2025
Sangamo BioSciences USD 0 0 Jun/2022
Siemens EUR 56.02B 673M Sep/2025
Sonic Healthcare AUD 4.8B 282.9M Dec/2024
Thermo Fisher Scientific USD 39.39B 3.7B Dec/2025
Veracyte USD 40.45M 10.19M Sep/2025
Waters USD 1.49B 52.2M Sep/2025